| Cost and effectiveness of one session treatment (OST) for children and young people with specific phobias compared to multi-session cognitive behavioural therapy (CBT): results from a randomised controlled trial | | 2022 |
| The Effect of the Drug Life Cycle Price on Cost-Effectiveness: Case Studies Using Real-World Pricing Data | | 2022 |
| Relationship between Serum Ferritin and Outcomes in β-Thalassemia: A Systematic Literature Review | | 2022 |
| Health-related quality-of-life and health-utility reporting in critical care | World Journal of Critical Care Medicine | 2022 |
| Estimating the impact of changes in weight and BMI on EQ-5D-3L: a longitudinal analysis of a behavioural group-based weight loss intervention | Quality of Life Research | |
| Routine fixation of humeral shaft fractures is cost-effective | Bone & Joint Open | 2022 |
| Dynamic and Flexible Survival Models for Extrapolation of Relative Survival: A Case Study and Simulation Study | Medical Decision Making | |
| Cost-utility analysis of cast compared to removable brace in the management of adult patients with ankle fractures | Bone & Joint Open | 2022 |
| Health Economic Analysis of the Integrated Cognitive Assessment Tool to Aid Dementia Diagnosis in the United Kingdom | | |
| Local Instrumental Variable Methods to Address Confounding and Heterogeneity when Using Electronic Health Records: An Application to Emergency Surgery | Medical Decision Making | |
| Capturing the value of vaccination within health technology assessment and health economics: Country analysis and priority value concepts | Vaccine | 2022 |
| Stick or twist? Cost-effectiveness of siponimod compared with continuing existing disease-modifying therapies in the treatment of active secondary progressive multiple sclerosis in the UK. | Journal of Medical Economics | 2022 |
| Cost-effectiveness analysis of the Oncotype DX Breast Recurrence Score® test in node-positive early breast cancer. | Journal of Medical Economics | 2022 |
| The Development of the EQ-5D-5L and its Value Sets | | 2022 |
| Challenges in Using Recommended Quality of Life Measures to Assess Fluctuating Health: A Think-Aloud Study to Understand How Recall and Timing of Assessment Influence Patient Responses | Patient | 2021 |
| Non-disease specific patient-reported outcome measures of health-related quality of life in juvenile idiopathic arthritis: a systematic review of current research and practice. | Rheumatology International | 2021 |
| Out of Date or Best Before? A Commentary on the Relevance of Economic Evaluations Over Time | Pharmacoeconomics | 2021 |
| A randomized controlled trial of a proportionate universal parenting program delivery model (E-SEE Steps) to enhance child social-emotional wellbeing. | PLoS ONE | 2022 |
| The Cost Effectiveness of Levodopa-Carbidopa Intestinal Gel in the Treatment of Advanced Parkinson's Disease in England. | Pharmacoeconomics | 2022 |
| Capturing what matters: updating NICE methods guidance on measuring and valuing health. | Quality of Life Research | 2022 |
| Transarterial Radioembolization Versus Atezolizumab-Bevacizumab in Unresectable Hepatocellular Carcinoma: A Matching-Adjusted Indirect Comparison of Time to Deterioration in Quality of Life. | Advances in Therapy | 2022 |
| Mid-Term Outcomes of Laparoscopic Gastric Greater Curvature Plication versus Roux-en-Y Gastric Bypass: Weight Loss, Gastrointestinal Symptoms, and Health-Related Quality of Life. | Medicina (Lithuania) | 2021 |
| Cost-effectiveness and value of information analysis of NephroCheck and NGAL tests compared to standard care for the diagnosis of acute kidney injury | BMC Nephrology | 2021 |
| Cost-effectiveness model of renal cell carcinoma (RCC) surveillance in hereditary leiomyomatosis and renal cell carcinoma (HLRCC). | Journal of Medical Genetics | 2022 |
| A Systematic Literature Review of the Relationship between Serum Ferritin and Outcomes in Myelodysplastic Syndromes. | Journal of Clinical Medicine | 2022 |
| A pilot economic evaluation of a feasibility trial for SUpporting wellbeing through PEeR-Befriending (SUPERB) for post-stroke aphasia. | Clinical Rehabilitation | 2022 |
| Generating EQ-5D-5L health utility scores from BASDAI and BASFI: a mapping study in patients with axial spondyloarthritis using longitudinal UK registry data. | European Journal of Health Economics | 2022 |
| Challenges of modelling approaches for network meta-analysis of time-to-event outcomes in the presence of non-proportional hazards to aid decision making: Application to a melanoma network. | Statistical Methods in Medical Research | 2022 |
| Economic Evaluation of Umeclidinium/Vilanterol versus Umeclidinium or Salmeterol in Symptomatic Non-Exacerbating Patients with COPD from a UK Perspective Using the GALAXY Model. | International Journal of COPD | 2021 |
| Children and Young People's Health Partnership Evelina London Model of Care: economic evaluation protocol of a complex system change | BMJ Open | 2021 |
| The Cambridge Cognitive and Psychiatric Assessment Kit (CamCOPS): A Secure Open-Source Client-Server System for Mobile Research and Clinical Data Capture | Frontiers in Psychiatry | 2021 |
| Steps in implementing a health economic evaluation | RMD Open | 2020 |
| Mobile Health App (AGRIPPA) to Prevent Relapse After Successful Interdisciplinary Treatment for Patients With Chronic Pain: Protocol for a Randomized Controlled Trial | JMIR Research Protocols | 2020 |
| A Cost-utility Analysis of Endovascular Aneurysm Repair for Abdominal Aortic Aneurysm | The Journal of Japanese College of Angiology | 2016 |
| Evaluating quality of life and cost implications of prophylactic radiotherapy in mesothelioma: Health economic analysis of the SMART trial | PLoS ONE | 2018 |
| An Introduction to EQ-5D Instruments and Their Applications | | 2020 |
| Discrepancies between proxy estimates and patient reported, health related, quality of life: minding the gap between patient and clinician perceptions in heart failure | Quality of Life Research | 2021 |
| Indirect and Direct Mapping of the Cancer-Specific EORTC QLQ-C30 onto EQ-5D-5L Utility Scores | Applied Health Economics and Health Policy | 2021 |
| Avoiding Opportunity Cost Neglect in Cost-Effectiveness Analysis for Health Technology Assessment | Applied Health Economics and Health Policy | 2021 |
| The cost-effectiveness of an adjuvanted quadrivalent influenza vaccine in the United Kingdom | Human Vaccines and Immunotherapeutics | 2021 |
| What Aspects of Illness Influence Public Preferences for Healthcare Priority Setting? A Discrete Choice Experiment in the UK | Pharmacoeconomics | 2021 |
| Costs and Cost-Effectiveness of User-Testing of Health Professionals' Guidelines to Reduce the Frequency of Intravenous Medicines Administration Errors by Nurses in the United Kingdom: A Probabilistic Model Based on Voriconazole Administration | Applied Health Economics and Health Policy | 2021 |
| Development and Validation of a Preference-Based Glaucoma Utility Instrument Using Discrete Choice Experiment | JAMA Ophthalmology | 2021 |
| Early detection of neovascular age-related macular degeneration: an economic evaluation based on data from the EDNA study | British Journal of Ophthalmology | 2021 |
| Reference data among general population and known-groups validity among hypertensive population of the EQ-5D-5L in Vietnam | Quality of Life Research | 2021 |
| Cost-effectiveness of procedure-less intragastric balloon therapy as substitute or complement to bariatric surgery | PLoS ONE | 2021 |
| Cost-effectiveness of surgery versus cast immobilization for adults with a bicortical fracture of the scaphoid waist : an economic evaluation of the SWIFFT trial | Bone and Joint Journal | 2021 |
| The Cost-Effectiveness of Expanding Vaccination with a Cell-Based Influenza Vaccine to Low Risk Adults Aged 50 to 64 Years in the United Kingdom | Vaccines | 2021 |
| Neutral theory: applicability and neutrality of using generic health-related quality of life tools in diseases or conditions where specific tools are available | BMC Medical Research Methodology | 2021 |
| Plate fixation of midshaft clavicle fractures for delayed union and non-union is a cost-effective intervention but functional deficits persist at long-term follow-up | Shoulder and Elbow | |
| Modeling long-term health and economic implications of new treatment strategies for Parkinson's disease: an individual patient simulation study | Journal of Market Access & Health Policy | 2021 |
| Value-based payment models involving pharmaceutical services | | 2021 |
| Economic Evaluations of Gestational Diabetes Mellitus Screening: A Systematic Review | Journal of Epidemiology | 2021 |
| Is Protocolised Weaning that Includes Early Extubation Onto Non-Invasive Ventilation More Cost Effective Than Protocolised Weaning Without Non-Invasive Ventilation? Findings from the Breathe Study | PharmacoEconomics - Open | 2020 |
| The validation of published utility mapping algorithms: an example of EORTC QLQ-C30 and EQ-5D in non-small cell lung cancer | Health Economics Review | 2020 |
| Mapping the EORTC QLQ-C30 and QLQ-H&N35, onto EQ-5D-5L and HUI-3 indices in patients with head and neck cancer | Head and Neck | 2020 |
| Experience-Based Swedish TTO and VAS Value Sets for EQ-5D-5L Health States | Pharmacoeconomics | 2020 |
| Long-term cost-effectiveness of screening for fracture risk in a UK primary care setting: the SCOOP study | Osteoporosis International | 2020 |
| Whom should we ask? A systematic literature review of the arguments regarding the most accurate source of information for valuation of health states | Quality of Life Research | 2020 |
| Use of Patient Preference Studies in HTA Decision Making: A NICE Perspective | Patient | 2020 |
| Challenges of Systematic Reviews of Economic Evaluations: A Review of Recent Reviews and an Obesity Case Study | Pharmacoeconomics | 2020 |
| An Economic Evaluation of Voretigene Neparvovec for the Treatment of Biallelic RPE65-Mediated Inherited Retinal Dystrophies in the UK | Advances in Therapy | 2020 |
| The clinical and cost-effectiveness of supplemental parenteral nutrition in oncology | ESMO Open | 2020 |
| Cost-effectiveness analysis of ocriplasmin versus watchful waiting for treatment of symptomatic vitreomacular adhesion in the US | Journal of Comparative Effectiveness Research | 2020 |
| Parkinson's disease with early motor complications: predicting EQ-5D- 3L utilities from PDQ-39 data in the EARLYSTIM trial | Health and Quality of Life Outcomes | 2020 |
| Cost-Effectiveness Analysis of Sequential Biologic Therapy with Ixekizumab Versus Secukinumab in the Treatment of Active Psoriatic Arthritis with Concomitant Moderate-to-Severe Psoriasis in the UK | PharmacoEconomics - Open | 2020 |
| An EQ-5D-5L Value Set for Vietnam | Quality of Life Research | 2020 |
| Enhanced recovery following hip and knee arthroplasty: a systematic review of cost-effectiveness evidence | BMJ Open | 2020 |
| Economic evaluation alongside the Speed of Increasing milk Feeds Trial (SIFT) | Archives of Disease in Childhood: Fetal and Neonatal Edition | 2020 |
| Cytoreductive surgery (CRS) with hyperthermic intraoperative peritoneal chemotherapy (HIPEC) versus standard of care (SoC) in people with peritoneal metastases from colorectal, ovarian or gastric origin: protocol for a systematic review and individual participant data (IPD) meta-analyses of effectiveness and cost-effectiveness | BMJ Open | 2020 |
| Which interactions matter in economic evaluations? A systematic review and simulation study | BMC Medical Research Methodology | 2020 |
| An individually randomised controlled multi-centre pragmatic trial with embedded economic and process evaluations of early vocational rehabilitation compared with usual care for stroke survivors: study protocol for the RETurn to work After stroKE (RETAKE) trial | Trials | 2020 |
| Some reflections on the use of inappropriate comparators in CEA | Cost Effectiveness and Resource Allocation | 2020 |
| EQ-5D-3L health status and health state utilities of the oldest-old (85 +) in Germany: results from the AgeCoDe-AgeQualiDe study | Quality of Life Research | 2020 |
| Cost-benefit analysis of surveillance for surgical site infection following caesarean section | BMJ Open | 2020 |
| FIRST-line support for assistance in breathing in children (FIRST-ABC): a master protocol of two randomised trials to evaluate the non-inferiority of high-flow nasal cannula (HFNC) versus continuous positive airway pressure (CPAP) for non-invasive respiratory support in paediatric critical care | BMJ Open | 2020 |
| Using qualitative methods for a conceptual analysis of measures of health status and presenteeism prior to a mapping study | Quality of Life Research | 2020 |
| The Forearm Fracture Recovery in Children Evaluation (FORCE) trial: statistical and health economic analysis plan for an equivalence randomized controlled trial of treatment for torus fractures of the distal radius in children | Bone & Joint Open | 2020 |
| A comparison of partitioned survival analysis and state transition multi-state modelling approaches using a case study in oncology | Journal of Medical Economics | 2020 |
| Cost Effectiveness of Teplizumab for Prevention of Type 1 Diabetes Among Different Target Patient Groups | Pharmacoeconomics | 2020 |
| Costs of joint replacement in osteoarthritis: a study using the National Joint Registry and Clinical Practice Research Datalink datasets | Arthritis Care and Research | 2020 |
| Protocol for the economic evaluation of metacognitive therapy for cardiac rehabilitation participants with symptoms of anxiety and/or depression | BMJ Open | 2020 |
| Mapping the University of Washington Quality of life questionnaire onto EQ-5D and HUI-3 indices in patients with head and neck cancer | Head and Neck | 2020 |
| How Uncertain is the Survival Extrapolation? A Study of the Impact of Different Parametric Survival Models on Extrapolated Uncertainty About Hazard Functions, Lifetime Mean Survival and Cost Effectiveness | Pharmacoeconomics | 2020 |
| How should we assess the clinical and cost effectiveness of histology independent cancer drugs? | BMJ, The | 2020 |
| Detachable low dead space syringes for the prevention of hepatitis C among people who inject drugs in Bristol, UK: an economic evaluation | Addiction | 2020 |
| Cost-effectiveness of e-cigarettes compared with nicotine replacement therapy in stop smoking services in England (TEC study): a randomized controlled trial | Addiction | 2020 |
| A quality-of-life mapping function developed from a grass pollen sublingual immunotherapy trial to a tree pollen sublingual immunotherapy trial | Journal of Medical Economics | 2020 |
| Cost Effectiveness of PD-L1-Based Test-and-Treat Strategy with Pembrolizumab as the First-Line Treatment for Metastatic NSCLC in Hong Kong | PharmacoEconomics - Open | 2020 |
| Influence of elicitation procedure and phrasing on health state valuations in experience-based time trade-off tasks among diabetes patients in China | Quality of Life Research | 2020 |
| Conducting a Time Trade-Off Study Alongside a Clinical Trial: A Case Study and Recommendations | PharmacoEconomics - Open | 2019 |
| Ibrutinib for Treating Relapsed or Refractory Mantle Cell Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal | Pharmacoeconomics | 2019 |
| Sensitivity of EQ-5D-3L, HUI2, HUI3, and SF-6D to changes in speech reception and tinnitus associated with cochlear implantation | Quality of Life Research | 2019 |
| Mapping the Positive and Negative Syndrome Scale scores to EQ-5D-5L and SF-6D utility scores in patients with schizophrenia | Quality of Life Research | 2019 |
| On estimands and the analysis of adverse events in the presence of varying follow-up times within the benefit assessment of therapies | Pharmaceutical Statistics | 2019 |
| Obinutuzumab in Combination with Chemotherapy for the First-Line Treatment of Patients with Advanced Follicular Lymphoma : An Evidence Review Group Evaluation of the NICE Single Technology Appraisal | Pharmacoeconomics | 2019 |
| Cost-effectiveness of prenatal screening and diagnostic strategies for Down syndrome: A microsimulation modeling analysis | PLoS ONE | 2019 |
| Towards UK poSt Arthroplasty Follow-up rEcommendations (UK SAFE): protocol for an evaluation of the requirements for arthroplasty follow-up, and the production of consensus-based recommendations | BMJ Open | 2019 |
| Is the Validity of Cost Utility Analysis Improved When Utility is Measured by an Instrument with ‘Home-Country’ Weights? Evidence from Six Western Countries | Social Indicators Research | 2019 |
| A brief introduction to health economics | Knee Surgery, Sports Traumatology, Arthroscopy | 2019 |
| Gallstone Disease | | 2019 |
| Estimating utilities/disutilities for high-risk metastatic hormone-sensitive prostate cancer (mHSPC) and treatment-related adverse events | Quality of Life Research | 2019 |
| Systematic Review of Decision Analytic Modelling in Economic Evaluations of Low Back Pain and Sciatica | Applied Health Economics and Health Policy | 2019 |
| Incorporating Future Medical Costs: Impact on Cost-Effectiveness Analysis in Cancer Patients | Pharmacoeconomics | 2019 |
| The Clinical and Cost Effectiveness of Inotuzumab Ozogamicin for the Treatment of Adult Relapsed or Refractory B-Cell Acute Lymphoblastic Leukaemia: An Evidence Review Group Evaluation of a NICE Single Technology Appraisal | Pharmacoeconomics | 2019 |
| Cost-Effectiveness Analysis of Fulvestrant 500 mg in Endocrine Therapy-Naïve Postmenopausal Women with Hormone Receptor-Positive Advanced Breast Cancer in the UK | PharmacoEconomics - Open | 2019 |
| EQ-5D-5L population norms and health inequalities for Trinidad and Tobago | PLoS ONE | 2019 |
| The impact of diagnosis on health-related quality of life in people with coeliac disease: a UK population-based longitudinal perspective | BMC Gastroenterology | 2019 |
| Access to health care for older people with intellectual disability: a modelling study to explore the cost-effectiveness of health checks | BMC Public Health | 2019 |
| Intelligent liver function testing (iLFT): A trial of automated diagnosis and staging of liver disease in primary care | Journal of Hepatology | 2019 |
| Planned delivery or expectant management for late preterm pre-eclampsia: study protocol for a randomised controlled trial (PHOENIX trial) | Trials | 2019 |
| A Review of the Development and Application of Generic Preference-Based Instruments with the Older Population | Applied Health Economics and Health Policy | 2019 |
| A Cost-Effectiveness Analysis of Newborn Screening for Severe Combined Immunodeficiency in the UK | International Journal of Neonatal Screening | 2019 |
| The Role of Real-World Evidence in UK Reimbursement: Case Study of Lenalidomide in Myelodysplastic Syndrome Deletion 5q | PharmacoEconomics - Open | 2019 |
| Chronic hepatitis B virus case-finding in UK populations born abroad in intermediate or high endemicity countries: an economic evaluation | BMJ Open | 2019 |
| Cost-Effectiveness Evaluations of Psychological Therapies for Schizophrenia and Bipolar Disorder: A Systematic Review | International Journal of Technology Assessment in Health Care | 2019 |
| Cost-effectiveness and satisfaction following arthroscopic rotator cuff repair: does age matter? | Bone and Joint Journal | 2019 |
| Routine fixation of displaced midshaft clavicle fractures is not cost-effective: a cost analysis from a randomized controlled trial | Bone and Joint Journal | 2019 |
| Micro-costing and a cost-consequence analysis of the 'Girls Active' programme: A cluster randomised controlled trial | PLoS ONE | 2019 |
| Can We Accurately Predict Cost Effectiveness Without Access to Overall Survival Data? The Case Study of Nivolumab in Combination with Ipilimumab for the Treatment of Patients with Advanced Melanoma in England | PharmacoEconomics - Open | 2019 |
| Does multidisciplinary rehabilitation of tortured refugees represent 'value-for-money'? A follow-up of a Danish case-study | BMC Health Services Research | 2018 |
| A community-based physical activity intervention to prevent mobility-related disability for retired older people (REtirement in ACTion (REACT)): study protocol for a randomised controlled trial | Trials | 2018 |
| Benefits in pain perception, ability function and health-related quality of life in patients with failed back surgery syndrome undergoing spinal cord stimulation in a clinical practice setting | Health and Quality of Life Outcomes | 2018 |
| The economic impact of sight loss and blindness in the UK adult population | BMC Health Services Research | 2018 |
| A utility valuation study assessing the impact of postprandial glucose control on quality of life of individuals with type 1 or type 2 diabetes | Journal of Patient-Reported Outcomes | 2017 |
| Systematic review and network meta-analysis of clinical outcomes associated with isavuconazole versus relevant comparators for patients with invasive aspergillosis | Current Medical Research and Opinion | 2018 |
| Probabilistic Sensitivity Analysis in Cost-Effectiveness Models: Determining Model Convergence in Cohort Models | Pharmacoeconomics | 2018 |
| RE: Cost-effectiveness of sacubitril/valsartan versus enalapril in patients with heart failure and reduced ejection fraction | Journal of Medical Economics | 2018 |
| Will the reformed Cancer Drugs Fund address the most common types of uncertainty? An analysis of NICE cancer drug appraisals | BMC Health Services Research | 2018 |
| An intervention to support stroke survivors and their carers in the longer term (LoTS2Care): study protocol for a cluster randomised controlled feasibility trial | Trials | 2018 |
| A Modeling Study of the Cost-Effectiveness of a Risk-Stratified Surveillance Program for Melanoma in the United Kingdom | Value in Health | 2018 |
| A descriptive system for the Infant health-related Quality of life Instrument (IQI): Measuring health with a mobile app | PLoS ONE | 2018 |
| Evidence-based surgery | Surgery | 2018 |
| A health state utility valuation study to assess the impact of treatment mode of administration in Gaucher disease | Orphanet Journal of Rare Diseases | 2018 |
| Systematic review of health state utility values in metastatic non-small cell lung cancer with a focus on previously treated patients | Health and Quality of Life Outcomes | 2018 |
| Cost-Utility of an Objective Biochemical Measure to Improve Adherence to Antihypertensive Treatment | Hypertension | 2018 |
| SYSTEMATIC REVIEWS OF ECONOMIC EVALUATIONS IN HEALTH TECHNOLOGY ASSESSMENT: A REVIEW OF CHARACTERISTICS AND APPLIED METHODS | International Journal of Technology Assessment in Health Care | 2018 |
| Intravesical device-assisted therapies for non-muscle-invasive bladder cancer | Nature Reviews Urology | 2018 |
| At-risk registers integrated into primary care to stop asthma crises in the UK (ARRISA-UK): study protocol for a pragmatic, cluster randomised trial with nested health economic and process evaluations | Trials | 2018 |
| Assessing utility values for treatment-related health states of acute myeloid leukemia in the United States | Health and Quality of Life Outcomes | 2018 |
| Cost-Effectiveness Analysis of the Use of Point-of-Care C-Reactive Protein Testing to Reduce Antibiotic Prescribing in Primary Care | Antibiotics | 2018 |
| Economic outcomes associated with deep surgical site infection in patients with an open fracture of the lower limb | Bone and Joint Journal | 2018 |
| WHICH DATABASES SHOULD BE USED TO IDENTIFY STUDIES FOR SYSTEMATIC REVIEWS OF ECONOMIC EVALUATIONS? | International Journal of Technology Assessment in Health Care | 2018 |
| Valuation of EuroQol Five-Dimensional Questionnaire, Youth Version (EQ-5D-Y) and EuroQol Five-Dimensional Questionnaire, Three-Level Version (EQ-5D-3L) Health States: The Impact of Wording and Perspective | Value in Health | 2018 |
| ALternatives To prophylactic Antibiotics for the treatment of Recurrent urinary tract infection in women (ALTAR): study protocol for a multicentre, pragmatic, patient-randomised, non-inferiority trial | Trials | 2018 |
| Incorporating MCDA into HTA: challenges and potential solutions, with a focus on lower income settings | Cost Effectiveness and Resource Allocation | 2018 |
| Shunt surgery in idiopathic normal pressure hydrocephalus is cost-effective-a cost utility analysis | Acta Neurochirurgica | 2018 |
| Adjuvant Statin Therapy for Esophageal Adenocarcinoma: A Cost-Utility Analysis | Pharmacoeconomics | 2018 |
| Cost-effectiveness of age-related macular degeneration study supplements in the UK: combined trial and real-world outcomes data | British Journal of Ophthalmology | 2018 |
| Do capability and functioning differ? A study of U.K. survey responses | Health Economics (United Kingdom) | 2018 |
